Everolimus (RAD001) 99% HPLC – Research-Grade mTORC1 Inhibitor Supplied by Finetech Industry Limited
Product Name: Everolimus
CAS Number: 159351-69-6
Product Number: FT-0654851
Molecular Formula: C₅₃H₈₃NO₁₄
Molecular Weight: 958.22 g/mol
Purity: 99% (HPLC)
Appearance: White to light yellow powder
Identification: ¹H-NMR, LC-MS
Packaging: 1 g, 5 g, 25 g
1. Product Overview
Everolimus, also known as RAD001, is a semi-synthetic macrocyclic lactone derived from rapamycin (sirolimus). It is widely used as a research compound for investigating the mammalian target of rapamycin (mTOR) signaling pathway, which plays an important role in regulating cell growth, metabolism, proliferation, and autophagy.
Everolimus acts through binding to FK506-binding protein 12 (FKBP12). The resulting complex interacts with and inhibits mechanistic target of rapamycin complex 1 (mTORC1), affecting downstream signaling pathways involved in cellular growth and protein synthesis.
With a defined molecular structure and high-purity specification, Everolimus is a useful research reagent for cellular signaling studies, cancer biology, and pharmaceutical discovery programs.
2. Chemical Specifications
| ParameterSpecification | |
| Product Name | Everolimus |
| CAS Number | 159351-69-6 |
| Product Number | FT-0654851 |
| Molecular Formula | C₅₃H₈₃NO₁₄ |
| Molecular Weight | 958.22 g/mol |
| Appearance | White to light yellow powder |
| Purity | 99% (HPLC) |
| Identification | ¹H-NMR, LC-MS |
| Packaging | 1 g, 5 g, 25 g |
| Intended Use | Research use only |
3. Chemical Structure and Biological Characteristics
Everolimus contains a complex macrocyclic structure with multiple oxygen-containing functional groups and a hydroxyethyl-substituted side chain. Its structural relationship to rapamycin gives it the ability to interact with FKBP12 and modulate mTORC1 activity.
The FKBP12–Everolimus complex inhibits mTORC1-mediated signaling and can influence the phosphorylation of downstream proteins, including S6 kinase and 4E-BP1. These proteins are associated with the regulation of protein translation, cell growth, and proliferation.
Because mTOR signaling is involved in several fundamental cellular processes, Everolimus is frequently used as a pharmacological tool in laboratory investigations of intracellular signaling networks.
4. Research Applications of Everolimus
4.1 mTOR Signaling Pathway Research
One of the primary research applications of Everolimus is the investigation of mTORC1 signaling. Researchers use it to study the regulation of downstream proteins, cellular nutrient responses, protein synthesis, and growth-related signaling.
It can serve as a pathway-modulating compound in experiments designed to evaluate the biological consequences of mTORC1 inhibition.
4.2 Cancer Biology and Drug Discovery
The mTOR signaling pathway is associated with cell proliferation, metabolism, and survival. Everolimus is therefore used in cancer biology research to investigate the relationship between mTORC1 activity and tumor-associated cellular processes.
In pharmaceutical discovery programs, it may be incorporated into experimental studies evaluating pathway inhibitors, combination strategies, and cellular responses to targeted compounds.
4.3 Autophagy and Cellular Metabolism
mTORC1 is an important regulator of autophagy, a cellular process involved in the degradation and recycling of intracellular components.
By modulating mTORC1 activity, Everolimus can be used in laboratory models investigating autophagic responses, intracellular nutrient sensing, and metabolic regulation.
4.4 Cell Growth and Proliferation Studies
Everolimus is also relevant to studies of cell-cycle regulation, protein synthesis, and cellular proliferation. Researchers can use it as an experimental tool to examine how changes in mTORC1 signaling affect cellular growth under different laboratory conditions.
4.5 Pharmaceutical Research and Experimental Model Development
As a well-characterized mTOR pathway inhibitor, Everolimus can support the development of experimental models for investigating signaling mechanisms and evaluating candidate compounds. It is suitable for research programs involving molecular pharmacology, cell biology, and drug discovery.
5. Everolimus Supply from Finetech Industry Limited
Finetech Industry Limited supplies research-grade Everolimus (CAS 159351-69-6), catalog number FT-0654851, for pharmaceutical research, molecular biology, and drug discovery applications.
The product is available with a 99% HPLC purity specification, with ¹H-NMR and LC-MS identification methods.
Available packaging:
- 1 g
- 5 g
- 25 g
For larger quantities, customized packaging, or specific project requirements, please contact our sales team for further information.
Finetech Industry Limited supports international research customers with chemical sourcing, product quality coordination, and professional supply services.
6. Why Choose Finetech Industry Limited?
- Research Chemical Supply: A range of specialty compounds for pharmaceutical and life science research.
- Quality Specifications: Product specifications supported by appropriate analytical identification and purity information.
- Flexible Packaging: Multiple package sizes to accommodate different research requirements.
- Custom Sourcing: Support for specialty chemicals and research intermediates.
- Professional Support: Responsive communication and assistance with product and order inquiries.
- International Supply: Chemical supply services for customers across global markets.
7. Contact Finetech Industry Limited
For inquiries about Everolimus, CAS 159351-69-6, product number FT-0654851, bulk quantities, or customized supply requirements, please contact Finetech Industry Limited.
Website: https://www.finetechnology-ind.com/
Note: This product is supplied for research use only.